Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Akhurst

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|June 13, 2019
Characteristics and outcomes of therapy-related myeloid neoplasms after peptide receptor radionuclide/chemoradionuclide therapy (PRRT/PRCRT) for metastatic neuroendocrine neoplasia: a single-institution seriesIsaac Goncalves, Kate Burbury, Michael Michael, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 7, 2020
Prognostic biomarkers in men with metastatic castration-resistant prostate cancer receiving [177Lu]-PSMA-617Justin Ferdinandus, John Violet, Shahneen Sandhu, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|May 31, 2019
The role of <sup>18</sup>F-FDG-PET/CT in evaluating retroperitoneal masses -Keeping your eye on the ball!Te-Jui Hung, Luke McLean, Catherine Mitchell, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 26, 2025
Safety and efficacy of re-treatment with [<sup>177</sup>Lu]Lu-DOTA-Octreotate radionuclide therapy in progressive gastro-entero-pancreatic neuroendocrine tumours - a single centre experienceRaghava Kashyap, Ramin Alipour, Emma Boehm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2003
Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: results of a prospective trialRobert J Downey, Tim Akhurst, David Ilson, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 14, 2019
PET-detected pneumonitis following curative-intent chemoradiation in non-small cell lung cancer (NSCLC): recognizing patterns and assessing the impact on the predictive ability of FDG-PET/CT response assessmentAmir Iravani, Guy-Anne Turgeon, Tim Akhurst, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 2002
Cells exposed to antifolates show increased cellular levels of proteins fused to dihydrofolate reductase: a method to modulate gene expressionPhilipp Mayer-Kuckuk, Debabrata Banerjee, Sundeep Malhotra, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 22, 2018
What <sup>18</sup>F-FDG PET Response-Assessment Method Best Predicts Survival After Curative-Intent Chemoradiation in Non-Small Cell Lung Cancer: EORTC, PERCIST, Peter Mac Criteria, or Deauville Criteria?Guy-Anne Turgeon, Amir Iravani, Tim Akhurst, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 12, 2022
Diagnostic performance of positron emission tomography in the staging of pseudomyxoma peritoneiMichael P Flood, Joseph C Kong, Toan Pham, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 29, 2003
Imaging of dihydrofolate reductase fusion gene expression in xenografts of human liver metastases of colorectal cancer in living ratsPhilipp Mayer-Kuckuk, Mikhail Doubrovin, Niraj J Gusani, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
European Journal of Nuclear Medicine and Molecular Imaging|June 13, 2019
Characteristics and outcomes of therapy-related myeloid neoplasms after peptide receptor radionuclide/chemoradionuclide therapy (PRRT/PRCRT) for metastatic neuroendocrine neoplasia: a single-institution seriesIsaac Goncalves, Kate Burbury, Michael Michael, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 7, 2020
Prognostic biomarkers in men with metastatic castration-resistant prostate cancer receiving [177Lu]-PSMA-617Justin Ferdinandus, John Violet, Shahneen Sandhu, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|May 31, 2019
The role of <sup>18</sup>F-FDG-PET/CT in evaluating retroperitoneal masses -Keeping your eye on the ball!Te-Jui Hung, Luke McLean, Catherine Mitchell, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 26, 2025
Safety and efficacy of re-treatment with [<sup>177</sup>Lu]Lu-DOTA-Octreotate radionuclide therapy in progressive gastro-entero-pancreatic neuroendocrine tumours - a single centre experienceRaghava Kashyap, Ramin Alipour, Emma Boehm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2003
Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: results of a prospective trialRobert J Downey, Tim Akhurst, David Ilson, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 14, 2019
PET-detected pneumonitis following curative-intent chemoradiation in non-small cell lung cancer (NSCLC): recognizing patterns and assessing the impact on the predictive ability of FDG-PET/CT response assessmentAmir Iravani, Guy-Anne Turgeon, Tim Akhurst, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 2002
Cells exposed to antifolates show increased cellular levels of proteins fused to dihydrofolate reductase: a method to modulate gene expressionPhilipp Mayer-Kuckuk, Debabrata Banerjee, Sundeep Malhotra, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 22, 2018
What <sup>18</sup>F-FDG PET Response-Assessment Method Best Predicts Survival After Curative-Intent Chemoradiation in Non-Small Cell Lung Cancer: EORTC, PERCIST, Peter Mac Criteria, or Deauville Criteria?Guy-Anne Turgeon, Amir Iravani, Tim Akhurst, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 12, 2022
Diagnostic performance of positron emission tomography in the staging of pseudomyxoma peritoneiMichael P Flood, Joseph C Kong, Toan Pham, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 29, 2003
Imaging of dihydrofolate reductase fusion gene expression in xenografts of human liver metastases of colorectal cancer in living ratsPhilipp Mayer-Kuckuk, Mikhail Doubrovin, Niraj J Gusani, et al.
Pageof 7